GN Store Nord (GN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Q1 2026 marked by the announced sale of the Hearing division, now treated as discontinued operations until expected closing by end-2026.
Continuing operations faced challenging EMEA markets, with strong growth in North America and APAC, and cost actions underway to support future margins.
Premium headset category grew over 50% year-over-year in Q1, driven by the Evolve3 launch.
Gaming division gained market share despite weak consumer sentiment, with new product launches expected to support future growth.
Group adjusted EBITA (continuing) was DKK 6 million (0–0.3% margin), down from 6% in Q1 2025, impacted by one-off costs.
Financial highlights
Revenue from continuing operations was DKK 2,096 million, down 8% year-over-year; organic growth at -4%.
Gross margin for continuing operations declined to 48.2% from 50.7% in Q1 2025, mainly due to Enterprise segment pressures.
Adjusted EBITA margin for continuing operations dropped to 0–0.3% from 5.7–6% year-over-year.
Free cash flow (excluding M&A) was negative DKK 45 million, reflecting seasonality and improved working capital management.
Net interest-bearing debt stood at DKK 8.9 billion, with leverage at 3.8x, down from 4.4x a year ago.
Outlook and guidance
2026 guidance for continuing operations: organic revenue growth of 0–6% and adjusted EBITA margin of 8–9%.
Enterprise division expected to deliver -3% to +3% organic growth; Gaming division 7–13%.
Structural cost savings of DKK 200 million targeted, with positive margin impact from 2027 and EBITA margin goal of 10–11%.
One-off cash costs of DKK 750 million expected for carve-out and restructuring, with 75% in 2026.
Latest events from GN Store Nord
- Hearing business sold to Amplifon for DKK 17B, enabling tech focus and global audiology leadership.GN
M&A announcement16 Mar 2026 - Guiding for 3%-7% organic growth and margin expansion in 2026, led by innovation and cost control.GN
Q4 20255 Feb 2026 - Pursuing margin expansion and growth through innovation in hearing, enterprise, and gaming.GN
SEB Nordic Seminar presentation5 Feb 2026 - 5% organic growth and margin gains, with strong Hearing and Gaming, guidance confirmed.GN
Q2 202423 Jan 2026 - Record cash flow and margin gains as Hearing outperformed, offsetting mixed divisional growth.GN
Q3 202416 Jan 2026 - Strong EBITDA growth, new board members, and strategic focus on innovation and resilience.GN
AGM 202520 Dec 2025 - Strong 2024 growth and margin gains set the stage for further expansion in 2025.GN
Q4 202417 Dec 2025 - Organic revenue fell 3%, but margin gains and new launches support cautious optimism.GN
Q1 202529 Nov 2025 - EBITA up 46% on margin gains, with Hearing strong and 2025 guidance narrowed amid tariff risks.GN
Q2 202523 Nov 2025